So I was right that they can essentially name anything more psychoactive than say tryptophan surprisingly schedule 4 making any tryptamine a analog of at least a schedule 4 if it's far enough from any of the more regular compounds that are not common in structure to dmtThis law essentially allows the attorney general to schedule drugs as he sees fit as long as it has a similar structure to any scheduled drug and is at least potentially psychoactive. This could be a huge blow to the legal NPS market if it is used extensively. It remains to be seen whether or not Sessions will use this to schedule huge swathes of drugs or just those that are getting a lot of media attention.
Order Amending Schedule III to the Controlled Drugs and Substances Act (Aminorex)
Amendments
1 Item 18 of Schedule III to the Controlled Drugs and Substances Act is repealed.
2 Item 27 of Schedule III to the Act is replaced by the following:
27 Aminorex (5-phenyl-4,5-dihydro-1,3-oxazol-2-amine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including
(1) 4-Methylaminorex (4-methyl-5-phenyl-4,5- dihydro-1,3-oxazol-2-amine)
(2) 4,4'-Dimethylaminorex (4-methyl-5-(4- methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)
Coming into Force
3 This Order comes into force on the day on which it is published in the Canada Gazette, Part II [December 13th, 2017].
1 Schedule I to the Controlled Drugs and Substances Act is amended by adding the following after item 25:
26 U-47700 (3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide), its salts, derivatives, isomers and analogues, and salts of derivatives, isomers and analogues, including
(1) Bromadoline (4-bromo-N-(2-(dimethylamino)cyclohexyl)benzamide)
(2) U-47109 (3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)benzamide)
(3) U-48520 (4-chloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide)
(4) U-50211 (N-(2-(dimethylamino)cyclohexyl)-4-hydroxy-N-methylbenzamide)
(5) U-77891 (3,4-dibromo-N-methyl-N-(1-methyl-1-azaspiro[4.5]decan-6-yl)benzamide)
2 Part 1 of Schedule VI to the Act is amended by adding the following after item 30:
31 N1,N1,N2-trimethylcyclohexane-1,2-diamine and its salts
Coming into Force
3 This Order comes into force on the day on which it is published in the Canada Gazette, Part II [December 27th, 2017].
Government of Canada said:DEPARTMENT OF HEALTH
CONTROLLED DRUGS AND SUBSTANCES ACT
Notice to interested parties -- Proposed Governor in Council Order amending schedules I and VI to the Controlled Drugs and Substances Act and proposed regulations amending the schedules to the Narcotic Control Regulations and the Precursor Control Regulations to capture additional substances used in the production of fentanyls and amphetamines
This notice provides interested stakeholders with the opportunity to provide comments on Health Canada's intent to amend the following schedules to the Controlled Drugs and Substances Act (CDSA) and its relevant regulations.
Schedule I to the CDSA
- Adding "4-Anilino-N-phenethylpiperidine (ANPP) (N-phenyl-1-(2-phenylethyl)piperidine-4-amine), its salts, derivatives, and analogues and salts of derivatives and analogues" as subitem (14) under item 16
Schedule VI to the CDSA
- Expanding item 9, Part 1, to include "and its derivatives, and analogues and salts of derivatives and analogues, including:
(1) methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (MMDMG)"
- Expanding item 11, Part 1, to include "and its derivatives, and analogues and salts of derivatives and analogues, including:
(1) methyl 2-methyl-3-phenyloxirane-2-carboxylate (BMK methyl glycidate)
(2) 3-oxo-2-phenylbutanamide (alpha-phenylacetoacetamide-APAA)"
- Expanding item 28, Part 1, to include "and its derivatives, and analogues and salts of derivatives and analogues"
- Adding "Benzylfentanyl (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide), its salts, derivatives, and analogues and salts of derivatives and analogues" as a new item in Part 1
Schedule to the Narcotic Control Regulations (NCR)
- Adding "4-Anilino-N-phenethylpiperidine (ANPP) (N-phenyl-1-(2-phenylethyl)piperidine-4-amine), its salts, derivatives, and analogues and salts of derivatives and analogues" as subitem (14) under item 15
Schedule to the Precursor Control Regulations (PCR)
- Expanding item 10 to include "and its derivatives, and analogues and salts of derivatives and analogues, including:
(1) methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (MMDMG)"
- Expanding item 13 to include "and its derivatives, and analogues and salts of derivatives and analogues, including:
(1) methyl 2-methyl-3-phenyloxirane-2-carboxylate (BMK methyl glycidate)
(2) 3-oxo-2-phenylbutanamide (α-phenylacetoacetamide-APAA)
- Expanding item 29 in Column 1 to include "and its derivatives, and analogues and salts of derivatives and analogues"
- Adding "Benzylfentanyl (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide), its salts, derivatives, and analogues and salts of derivatives and analogues" as a new item in Column 1 and indicating "0" in Column 2
Amendment
1 Schedule I to the Controlled Drugs and Substances Act is amended by adding the following after item 26:
- 27 Tramadol (2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol), its salts, isomers and salts of isomers and the following derivatives of tramadol and the salts, isomers and salts of isomers of these derivatives:
- (1) O-desmethyltramadol (3-[2[(dimethylamino)methyl]-1-hydroxycyclohexyl]-phenol)
- (2) N,O-didesmethyltramadol (3-[1-hydroxy-2-[(methylamino)methyl]cyclohexyl]-phenol)
The opposite. It will push desperate people to heroinAnd this is going to stop people from trying heroin?
Da Law said:Between 2006 and 2017, tramadol is suspected to have contributed to 71 adverse events related to problematic use, dependence or withdrawal reported in Canada,